- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 2 x HEA: HEME-A(Non-covalent)
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x PER: PEROXIDE ION(Non-covalent)
- 3 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
PGV.7: 30 residues within 4Å:- Chain A: F.94, P.95, R.96, M.97, M.100, F.148, H.151, L.152, L.159
- Chain C: H.9, V.11, G.20, A.24, M.27, T.28, N.50, T.53, M.54, W.57, W.58, V.61, E.64, H.71, L.79, G.82, F.86, S.89, E.90, F.93
- Ligands: PEK.38
19 PLIP interactions:8 interactions with chain A, 11 interactions with chain C- Hydrophobic interactions: A:F.148, A:L.152, A:L.159, C:A.24, C:T.28, C:T.53, C:W.57, C:W.57, C:W.57, C:W.58, C:F.86, C:F.86, C:F.93
- Hydrogen bonds: A:R.96, A:R.96, A:M.97, C:W.57
- Water bridges: A:A.93
- Salt bridges: A:R.96
PGV.33: 25 residues within 4Å:- Chain C: N.50, M.51, M.54, W.58, V.61, I.62, S.65, T.66, H.71, L.79, M.83, F.86, H.207, I.210, T.213, F.214, R.221, H.226, F.227, T.228, H.231, H.232, F.233, G.234
- Ligands: CDL.34
27 PLIP interactions:2 interactions with chain F, 25 interactions with chain C- Water bridges: F:Q.12, F:E.17, C:S.65, C:R.221, C:H.231, C:H.231
- Hydrophobic interactions: C:W.58, C:W.58, C:W.58, C:W.58, C:W.58, C:I.62, C:F.86, C:F.86, C:I.210, C:I.210, C:T.213, C:F.214, C:F.214, C:F.214
- Hydrogen bonds: C:S.65, C:R.221, C:F.233, C:G.234
- Salt bridges: C:R.221, C:R.221, C:H.231
PGV.47: 17 residues within 4Å:- Chain A: N.406, T.408, W.409, I.412, R.480
- Chain D: T.80, A.84, F.87, F.88
- Chain K: F.9, H.10
- Chain M: P.12, Q.15, A.16, L.19, S.20
- Ligands: CHD.70
9 PLIP interactions:2 interactions with chain M, 1 interactions with chain A, 4 interactions with chain D, 2 interactions with chain K- Hydrophobic interactions: M:P.12, M:A.16, A:I.412, D:F.87, D:F.87, D:F.87, D:F.88, K:F.9
- Water bridges: K:F.9
- 45 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.8: 6 residues within 4Å:- Chain A: F.505, E.507, P.508
- Chain F: R.56, I.57, W.73
Ligand excluded by PLIPEDO.9: 8 residues within 4Å:- Chain A: Y.19, M.71, P.72, I.75, G.76, L.105, S.156, S.157
Ligand excluded by PLIPEDO.10: 9 residues within 4Å:- Chain A: R.5, N.11, K.13, D.14, W.81, P.499, P.500, Y.502
- Chain L: N.10
Ligand excluded by PLIPEDO.11: 1 residues within 4Å:- Chain A: F.2
Ligand excluded by PLIPEDO.12: 6 residues within 4Å:- Chain A: H.256, T.259, K.265, T.490, N.491
- Ligands: EDO.53
Ligand excluded by PLIPEDO.13: 8 residues within 4Å:- Chain A: Y.260, Y.261, V.394, H.395, P.398, V.485, W.494
- Chain M: I.1
Ligand excluded by PLIPEDO.14: 9 residues within 4Å:- Chain A: L.483, T.484, V.485, T.488, W.494, G.497, C.498
- Chain D: Y.11
- Ligands: EDO.49
Ligand excluded by PLIPEDO.15: 8 residues within 4Å:- Chain A: K.265, E.266
- Chain B: T.55
- Chain F: N.66, T.68, I.70, S.84
- Ligands: EDO.54
Ligand excluded by PLIPEDO.16: 6 residues within 4Å:- Chain A: G.269, Y.270, M.271, G.272
- Chain B: E.62
- Ligands: CHD.27
Ligand excluded by PLIPEDO.17: 2 residues within 4Å:- Chain A: P.131, D.221
Ligand excluded by PLIPEDO.18: 6 residues within 4Å:- Chain A: E.507
- Chain C: T.5
- Chain F: P.30, N.32, L.96
- Ligands: EDO.58
Ligand excluded by PLIPEDO.19: 3 residues within 4Å:- Chain A: T.489
- Chain F: I.70, P.83
Ligand excluded by PLIPEDO.20: 6 residues within 4Å:- Chain A: L.33, V.57, A.60, S.116
- Chain L: I.39, V.40
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain A: V.485, D.486, L.487, T.488, T.489
- Ligands: EDO.49
Ligand excluded by PLIPEDO.22: 9 residues within 4Å:- Chain A: P.174, T.509, Y.510, V.511
- Chain F: N.32, L.34, P.36, R.56
- Ligands: EDO.58
Ligand excluded by PLIPEDO.23: 8 residues within 4Å:- Chain A: T.10, N.11, D.91, Y.502, H.503
- Chain C: M.10, V.11
- Ligands: EDO.79
Ligand excluded by PLIPEDO.24: 6 residues within 4Å:- Chain A: E.266, P.267, G.269, Y.270
- Chain F: S.67
- Ligands: EDO.54
Ligand excluded by PLIPEDO.29: 2 residues within 4Å:- Chain A: T.46
- Chain B: F.206
Ligand excluded by PLIPEDO.30: 7 residues within 4Å:- Chain A: Y.447
- Chain B: M.1, A.2, Q.10, L.136, P.166, Y.193
Ligand excluded by PLIPEDO.39: 9 residues within 4Å:- Chain C: W.146, S.150, D.155, H.158
- Chain F: A.1, S.2
- Chain G: A.13, R.14, R.17
Ligand excluded by PLIPEDO.40: 2 residues within 4Å:- Chain C: Q.4, H.70
Ligand excluded by PLIPEDO.41: 5 residues within 4Å:- Chain A: P.222, A.223
- Chain B: G.177
- Chain C: E.111
- Chain H: W.68
Ligand excluded by PLIPEDO.42: 4 residues within 4Å:- Chain C: P.73, A.74, K.77
- Chain F: I.33
Ligand excluded by PLIPEDO.43: 5 residues within 4Å:- Chain C: N.12, P.13
- Chain J: G.17, L.18, P.19
Ligand excluded by PLIPEDO.44: 5 residues within 4Å:- Chain C: T.145, H.148, H.149
- Chain G: T.11, W.16
Ligand excluded by PLIPEDO.49: 11 residues within 4Å:- Chain A: T.484, T.488, L.495
- Chain D: D.10, Y.11, L.13, P.14, S.15
- Ligands: EDO.14, EDO.21, EDO.55
Ligand excluded by PLIPEDO.50: 6 residues within 4Å:- Chain D: Y.22, D.26
- Chain E: W.27, R.30, K.31, N.34
Ligand excluded by PLIPEDO.51: 3 residues within 4Å:- Chain E: Y.18, K.21, E.28
Ligand excluded by PLIPEDO.53: 6 residues within 4Å:- Chain A: T.490
- Chain F: S.67, T.68, V.69, W.71
- Ligands: EDO.12
Ligand excluded by PLIPEDO.54: 7 residues within 4Å:- Chain A: E.266
- Chain F: D.65, N.66, S.67, T.68
- Ligands: EDO.15, EDO.24
Ligand excluded by PLIPEDO.55: 8 residues within 4Å:- Chain A: L.495
- Chain D: Y.11, A.12, L.13, P.14
- Chain F: F.72, W.73
- Ligands: EDO.49
Ligand excluded by PLIPEDO.56: 4 residues within 4Å:- Chain F: F.72, Q.80, R.81, P.83
Ligand excluded by PLIPEDO.57: 6 residues within 4Å:- Chain A: Y.510
- Chain F: P.36, K.37, T.39, N.47, L.48
Ligand excluded by PLIPEDO.58: 7 residues within 4Å:- Chain A: Y.510
- Chain F: N.32, P.36, P.50, R.56
- Ligands: EDO.18, EDO.22
Ligand excluded by PLIPEDO.59: 7 residues within 4Å:- Chain F: E.11, Q.12, A.13, T.14, R.18
- Chain J: Q.9
- Ligands: EDO.69
Ligand excluded by PLIPEDO.60: 4 residues within 4Å:- Chain C: P.73, H.231
- Chain F: D.9, E.17
Ligand excluded by PLIPEDO.63: 4 residues within 4Å:- Chain G: P.49, Y.50, H.51, P.79
Ligand excluded by PLIPEDO.64: 6 residues within 4Å:- Chain C: G.120
- Chain G: A.46, F.47, I.48, L.53, R.54
Ligand excluded by PLIPEDO.65: 6 residues within 4Å:- Chain C: W.34, F.35
- Chain G: K.58, P.59, F.60, S.61
Ligand excluded by PLIPEDO.66: 3 residues within 4Å:- Chain G: W.62, F.69
- Ligands: DMU.45
Ligand excluded by PLIPEDO.68: 2 residues within 4Å:- Chain I: R.16, H.20
Ligand excluded by PLIPEDO.69: 3 residues within 4Å:- Chain J: K.10, Q.13
- Ligands: EDO.59
Ligand excluded by PLIPEDO.78: 8 residues within 4Å:- Chain A: V.118, E.119
- Chain J: A.53, S.54, F.55, P.56
- Chain L: K.46, K.47
Ligand excluded by PLIPEDO.79: 4 residues within 4Å:- Chain C: P.13
- Chain L: H.2, Y.3
- Ligands: EDO.23
Ligand excluded by PLIPEDO.82: 6 residues within 4Å:- Chain A: T.46, L.47
- Chain D: V.103
- Chain M: L.37, D.38, K.41
Ligand excluded by PLIP- 3 x TGL: TRISTEAROYLGLYCEROL(Non-covalent)
TGL.25: 18 residues within 4Å:- Chain A: T.354, F.418, N.422, M.423, F.426, H.429, F.430, L.433
- Chain B: L.7, G.8, L.28, V.31, F.32, S.35, S.36, L.39
- Chain I: K.42, R.43
13 PLIP interactions:1 interactions with chain I, 6 interactions with chain A, 6 interactions with chain B- Salt bridges: I:R.43, B:H.24
- Hydrophobic interactions: A:T.354, A:F.418, A:N.422, A:F.426, A:F.426, A:F.430, B:V.31, B:F.32, B:L.39
- Water bridges: B:G.8, B:F.9
TGL.48: 17 residues within 4Å:- Chain A: W.334, M.339, G.343, F.414, A.415, V.419
- Chain B: L.39, I.42, L.46
- Chain D: R.73, T.75, E.77, W.78, V.81, V.82, M.86, I.89
16 PLIP interactions:8 interactions with chain D, 6 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: D:E.77, D:W.78, D:W.78, D:V.81, D:V.82, A:W.334, A:W.334, A:W.334, A:A.415, A:V.419, B:L.39, B:L.46
- Hydrogen bonds: D:T.75, D:E.77, D:W.78
- Salt bridges: A:K.411
TGL.77: 28 residues within 4Å:- Chain A: F.2, T.17, L.18, L.20, L.21, F.22, W.25, P.106, F.109, L.110, L.112, L.113, F.393, F.400, S.401, I.472
- Chain L: N.10, I.11, P.12, F.13, S.14, R.20, M.24, M.25, L.27, F.28, F.29, I.39
21 PLIP interactions:16 interactions with chain A, 5 interactions with chain L- Hydrophobic interactions: A:T.17, A:L.18, A:L.20, A:L.21, A:F.22, A:F.22, A:W.25, A:W.25, A:P.106, A:F.109, A:F.109, A:L.112, A:L.113, A:F.393, A:F.400, A:I.472, L:I.11, L:F.13, L:F.13, L:F.28, L:I.39
- 1 x CUA: DINUCLEAR COPPER ION(Non-covalent)
- 5 x CHD: CHOLIC ACID(Non-covalent)(Covalent)
CHD.27: 7 residues within 4Å:- Chain A: M.271, G.272, W.275
- Chain B: E.62, T.63, T.66
- Ligands: EDO.16
7 PLIP interactions:3 interactions with chain B, 4 interactions with chain A- Hydrogen bonds: B:E.62, B:T.63
- Water bridges: B:T.63
- Hydrophobic interactions: A:M.271, A:W.275, A:W.275, A:W.275
CHD.35: 8 residues within 4Å:- Chain C: R.156, K.157, L.160, Q.161, F.164, F.219, L.223
- Chain J: F.1
10 PLIP interactions:9 interactions with chain C, 1 interactions with chain J- Hydrophobic interactions: C:K.157, C:L.160, C:F.164, C:F.164, C:F.164, C:F.164, C:F.219, C:L.223
- Salt bridges: C:R.156
- Hydrogen bonds: J:F.1
CHD.37: 7 residues within 4Å:- Chain A: H.233, W.288, D.300, T.301, Y.304
- Chain C: W.99, H.103
8 PLIP interactions:5 interactions with chain A, 3 interactions with chain C- Hydrophobic interactions: A:W.288, A:Y.304, C:W.99
- Hydrogen bonds: A:T.301, C:W.99
- Water bridges: A:T.301
- Salt bridges: A:H.233, C:H.103
CHD.70: 7 residues within 4Å:- Chain K: A.16, A.19, S.20, T.23, F.24
- Ligands: PGV.47, DMU.75
4 PLIP interactions:4 interactions with chain K- Hydrophobic interactions: K:A.16, K:A.19, K:T.23
- Hydrogen bonds: K:T.23
CHD.80: 5 residues within 4Å:- Chain L: W.19, L.22, A.23
- Chain M: E.14, I.17
6 PLIP interactions:2 interactions with chain L, 4 interactions with chain M- Hydrophobic interactions: L:W.19, M:E.14, M:I.17, M:I.17
- Hydrogen bonds: L:A.23, M:E.14
- 1 x PSC: (7R,17E,20E)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSA-17,20-DIEN-1-AMINIUM 4-OXIDE(Non-covalent)
PSC.28: 22 residues within 4Å:- Chain A: F.268, F.321, L.324, A.325, H.328
- Chain B: I.41, M.45, H.52, T.55, M.56, D.57, E.60, V.61, I.64, W.65, P.69
- Chain E: E.6, D.8, F.11
- Chain I: R.10, A.14, L.17
14 PLIP interactions:9 interactions with chain B, 1 interactions with chain E, 4 interactions with chain A- Hydrophobic interactions: B:I.41, B:I.41, B:M.56, B:V.61, B:I.64, B:W.65, B:P.69, A:F.268, A:F.321, A:L.324, A:A.325
- Hydrogen bonds: B:D.57
- Salt bridges: B:H.52, E:D.8
- 11 x DMU: DECYL-BETA-D-MALTOPYRANOSIDE(Non-covalent)(Non-functional Binders)
DMU.31: 7 residues within 4Å:- Chain B: H.26, M.29, I.30, L.33, I.34, L.75
- Chain I: K.36
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain I- Hydrophobic interactions: B:I.34, B:L.75
- Salt bridges: B:H.26, I:K.36
- Hydrogen bonds: I:K.36
DMU.36: 13 residues within 4Å:- Chain A: L.110, A.114, L.145
- Chain C: S.29, M.33, F.37
- Chain J: Y.45, S.46, Y.48, C.49, L.50, W.52
- Ligands: DMU.46
8 PLIP interactions:2 interactions with chain C, 3 interactions with chain J, 3 interactions with chain A- Hydrophobic interactions: C:M.33, C:F.37, J:L.50, A:L.110, A:A.114, A:L.145
- Hydrogen bonds: J:Y.45, J:Y.45
DMU.45: 9 residues within 4Å:- Chain C: W.34, N.38, M.40
- Chain G: S.61, W.62, G.63, F.69
- Ligands: DMU.46, EDO.66
10 PLIP interactions:3 interactions with chain G, 7 interactions with chain C- Hydrophobic interactions: G:F.69, G:F.69, C:W.34, C:W.34
- Hydrogen bonds: G:G.63, C:W.34, C:N.38, C:N.38, C:N.38
- Water bridges: C:M.40
DMU.46: 11 residues within 4Å:- Chain C: N.38, S.39, T.41, I.45
- Chain J: T.37, L.38, G.41, G.42, Y.45
- Ligands: DMU.36, DMU.45
6 PLIP interactions:3 interactions with chain C, 3 interactions with chain J- Hydrogen bonds: C:N.38, C:S.39, C:S.39, J:Y.45
- Hydrophobic interactions: J:Y.45, J:Y.45
DMU.71: 7 residues within 4Å:- Chain A: M.423
- Chain D: I.89
- Chain K: V.26, W.29, V.30
- Ligands: DMU.74, DMU.75
4 PLIP interactions:1 interactions with chain D, 3 interactions with chain K- Hydrophobic interactions: D:I.89, K:W.29, K:W.29, K:W.29
DMU.72: 9 residues within 4Å:- Chain B: M.5
- Chain K: A.33, T.34, G.37, I.38, E.39, W.40
- Ligands: DMU.73, DMU.76
5 PLIP interactions:5 interactions with chain K- Hydrophobic interactions: K:W.40, K:W.40
- Hydrogen bonds: K:G.37, K:E.39
- Water bridges: K:W.40
DMU.73: 9 residues within 4Å:- Chain D: L.94, I.97, W.98, H.101
- Chain K: Y.31, Q.35, I.36, G.37
- Ligands: DMU.72
9 PLIP interactions:5 interactions with chain D, 4 interactions with chain K- Hydrophobic interactions: D:L.94, D:W.98
- Water bridges: D:K.100, D:K.100, K:T.34, K:Q.35, K:G.37
- Salt bridges: D:H.101
- Hydrogen bonds: K:Y.31
DMU.74: 6 residues within 4Å:- Chain K: V.30, A.33, T.34
- Ligands: DMU.71, DMU.75, DMU.76
2 PLIP interactions:2 interactions with chain K- Hydrophobic interactions: K:A.33, K:T.34
DMU.75: 6 residues within 4Å:- Chain K: T.23, F.24, A.27
- Ligands: CHD.70, DMU.71, DMU.74
3 PLIP interactions:3 interactions with chain K- Hydrophobic interactions: K:F.24, K:F.24, K:A.27
DMU.76: 2 residues within 4Å:- Ligands: DMU.72, DMU.74
No protein-ligand interaction detected (PLIP)DMU.81: 13 residues within 4Å:- Chain A: L.35, F.459
- Chain D: L.95, W.98, Y.102
- Chain M: L.27, L.28, A.30, G.31, W.32, L.34, Y.35, H.36
10 PLIP interactions:6 interactions with chain M, 2 interactions with chain A, 2 interactions with chain D- Hydrophobic interactions: M:L.27, M:A.30, M:L.34, A:L.35, A:F.459, D:L.95, D:W.98
- Water bridges: M:W.32, M:H.36, M:H.36
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 2 x HEA: HEME-A(Non-covalent)
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x PER: PEROXIDE ION(Non-covalent)
- 3 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
- 45 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 3 x TGL: TRISTEAROYLGLYCEROL(Non-covalent)
- 1 x CUA: DINUCLEAR COPPER ION(Non-covalent)
- 5 x CHD: CHOLIC ACID(Non-covalent)(Covalent)
- 1 x PSC: (7R,17E,20E)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSA-17,20-DIEN-1-AMINIUM 4-OXIDE(Non-covalent)
- 11 x DMU: DECYL-BETA-D-MALTOPYRANOSIDE(Non-covalent)(Non-functional Binders)